Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
563.1 INR | -1.13% |
|
-2.80% | +70.43% |
06-25 | Shilpa Medicare Bio Analytical Unit Gets "No Action Indicated" Classification from US FDA | MT |
05-24 | Transcript : Shilpa Medicare Limited, Q4 2024 Earnings Call, May 24, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+70.43% | 593M | |
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 314B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B |
- Stock Market
- Equities
- SHILPAMED Stock
- News Shilpa Medicare Limited
- Shilpa Medicare Bio Analytical Unit Gets "No Action Indicated" Classification from US FDA